Efficacy of tocilizumab in a patient with refractory psoriatic arthritis

JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis

(2014) Ugo Fiocco et al.   IMMUNOLOGIC RESEARCH

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

(2013) Iain B McInnes et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials

(2013) Radjiv Goulabchand et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients

(2013) Luisa Costa et al.   CLINICAL RHEUMATOLOGY

Psoriatic arthritis: advances in pharmacotherapy based on molecular target

(2013) Raffaele Scarpa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab

(2013) Francesco Caso et al.   IMMUNOLOGIC RESEARCH

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

(2013) Iain B McInnes et al.   LANCET

Successful use of tocilizumab in a patient with psoriatic arthritis

(2013) M. Hughes et al.   RHEUMATOLOGY

Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers

(2012) Ugo Fiocco et al.   JOINT BONE SPINE

Induction of severe systemic lupus erythematosus by TNF blockade and response to anti–IL-6 strategy

(2012) Sabine Adler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study

(2011) Raffaele Scarpa et al.   CLINICAL RHEUMATOLOGY

Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study

(2011) Luisa Costa et al.   CLINICAL RHEUMATOLOGY

Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab

(2011) Atsushi Ogata et al.   JOINT BONE SPINE

The ClASsification for Psoriatic ARthritis (CASPAR) Criteria - A Retrospective Feasibility, Sensitivity, and Specificity Study

(2011) W. TILLETT et al.   JOURNAL OF RHEUMATOLOGY

Work disability in psoriatic arthritis: a systematic review

(2011) W. Tillett et al.   RHEUMATOLOGY

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

(2010) Norma Jung et al.   CLINICAL RHEUMATOLOGY

Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs

(2010) Mariangela Atteno et al.   CLINICAL RHEUMATOLOGY

Psoriatic disease: concepts and implications

(2010) R Scarpa et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint

(2010) Ugo Fiocco et al.   ARTHRITIS RESEARCH & THERAPY

Interleukin-6 as a key player in systemic inflammation and joint destruction

(2009) J.E. Fonseca et al.   AUTOIMMUNITY REVIEWS